Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 39.05 BATS BZX Real-Time Price As of 1:55pm ET |  -0.73 / -1.84%Today’s Change | 37.59 Today|||52-Week Range 79.50 | -16.06% Year-to-Date |
Latest ENTA News | Press Releases
No recent news for Enanta Pharmaceuticals Inc.
Today’s Trading
| Previous close | 39.78 |
| Today’s open | 39.87 |
| Day’s range | 39.05 - 39.87 |
| Volume | 932 |
| Average volume (3 months) | 168,809 |
| Market cap | $841.7M |
Data as of 1:55pm ET, 03/28/2023
Growth & Valuation
| Earnings growth (last year) | -50.90% |
| Earnings growth (this year) | -35.14% |
| Earnings growth (next 5 years) | -83.30% |
| Revenue growth (last year) | -11.24% |
| P/E ratio | NM |
| Price/Sales | 12.40 |
| Price/Book | 2.59 |
Competitors
Data as of 1:54pm ET, 03/28/2023
Financials
| Next reporting date | May 9, 2023 |
| EPS forecast (this quarter) | -$1.96 |
| Annual revenue (last year) | $86.2M |
| Annual profit (last year) | -$121.8M |
| Net profit margin | -141.31% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
